Kintara Therapeuticsincis A Clinical Stage Biopharmaceutical Company Based In San Diegocaliforniafounded In 2015The Company Is Focused On Developing Innovative Therapies For Cancer Treatmentparticularly For Patients With Solid Tumors Who Have Unmet Medical Needskintara S Mission Is To Create Novel Cancer Therapies For Those Who Are Resistant To Existing Treatments The Company Utilizes A Proprietary Photodynamic Therapy Platform That Combines A Laser Light Sourcea Specialized Light Delivery Deviceand A Drug Productthis Technology Aims To Target Localized Tumorssuch As Cutaneous Metastatic Breast Cancerby Activating A Light Sensitive Compound To Destroy Tumor Cellskintara S Clinical Pipeline Includes Key Product Candidates Like Rem 001 Therapy For Cutaneous Metastatic Breast Cancerval 083 For Glioblastomaand Mt 3724 For Non Hodgkin Lymphomaamong Others In April 2024Kintara Announced A Merger With Tuhura Biosciencesinc Enhancing Its Capabilities In Cancer Treatmentwith A Market Capitalization Of Approximately $50 Millionkintara Is Committed To Advancing Its Research And Development Efforts In Oncology
No conferences found for this company.
| Company Name | Kintara Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
